ALICIA (Acalabrutinib in CLL Therapy)
NCT04746950
·
clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Sponsor
AstraZeneca